Dose-response relationships of rat fetal skeleton variations: Relevance for risk assessment

Environmental Research

Volumn 109, Issue 7, 2009, Pages 922-929

  Chahoud, Ibrahim ^a   Paumgartten, Francisco J R ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

5 Fluoro 2 deoxyuridine; 6 Mercaptopurine riboside; Hydroxyurea; No observed effect level; Skeleton malformations

Indexed keywords

FLOXURIDINE; HYDROXYUREA; MERCAPTOPURINE RIBOSIDE;

DOSE-RESPONSE RELATIONSHIP; DRUG; RISK ASSESSMENT; RODENT; SKELETON; TOXICOLOGY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CESAREAN SECTION; CLEFT PALATE; CONTROLLED STUDY; EARDRUM; FEMALE; FETUS; INCIDENCE; LUMBAR VERTEBRA; MAXILLA; NONHUMAN; PRIORITY JOURNAL; RAT; RIB; RISK ASSESSMENT; SKELETON MALFORMATION; STAINING; STERNUM; THORACIC SPINE; TIBIA; ZYGOMA;

6-MERCAPTOPURINE; ANIMALS; ANTINEOPLASTIC AGENTS; BONE AND BONES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FLOXURIDINE; HYDROXYUREA; MATERNAL EXPOSURE; PREGNANCY; RATS; RATS, WISTAR;

ANIMALIA; RATTUS;

EID: 69849094615     PISSN: 00139351     EISSN: 10960953     Source Type: Journal    
DOI: 10.1016/j.envres.2009.07.013     Document Type: Article

References (21)

1. Augustine-Rauch K. Alternative experimental approaches for interpreting skeletal findings in safety studies. Birth Defects Res. Part B 80 (2007) 497-504
2. Carney E.W., and Kimmel C.A. Interpretation of skeletal variations for human risk assessment: delayed ossification and wavy ribs. Birth Defects Res. Part B 80 (2007) 473-496
3. Chahoud I., Buschmann J., Clar k R., Druga A., Falke H., Faqi A., Hansen E., Heinrich-Hirsch B., Hellwig J., Lingk W., Parkinson M., Paumgartten F.J., Pfeil R., Platzek T., Scialli A.R., Seed J., Stahlmann R., Ulbrich B., Wu X., Yasuda M., Younes M., and Solecki R. Classification terms in developmental toxicology: need for harmonisation. Reprod. Toxicol. 13 (1999) 77-82
4. Chahoud I., Kuriyama S.N., and Paumgartten F.J. Maternal protein-and-energy restriction reduces the developmental toxicity of cyclophosphamide and hydroxyurea in rats. Toxicology 179 (2002) 137-149
5. Daston G.P., and Seed J. Skeletal malformations and variations in developmental toxicity studies. Interpretation issues for human risk assessment. Birth Defects Res. Part B 80 (2007) 421-424
6. De-Pass L.R., and Weaver E.V. Comparison of teratogenic effects of aspirin and hydroxyurea in the Fischer 344 and Wistar strains. J. Toxicol. Environ. Health 10 (1982) 297-305
7. Ferguson M.W.J. The teratogenic effects of 5-fluoro-2-deoxyuridine (F.U.D.R.) on the Wistar rat fetus, with particular reference to cleft palate. J. Anat. 126 (1978) 37-49
8. Igarashi, E., 1998. Anomalies of cartilaginous and ossified axial skeleton in rat fetuses treatzed with cyclophosphamide: type, frequency, and stage specificity. Con. Anom. 38, 39-55.
9. Kast A. "Wavy ribs". A reversible pathologic finding in rat fetuses. Exp. Toxicol. Pathol. 46 (1994) 203-210
10. Khera K.S. Common fetal aberrations and their teratologic significance: a review. Fundam. Appl. Toxicol. 1 (1981) 13-18
11. Lennard L. The clinical pharmacology of 6-mercaptopurine. Eur. J. Pharmacol. 43 (1992) 329-339
12. ® (Sprague-Dawley) rat skeleton after maternal exposure to ethylene glycol. Teratology 46 (1992) 169-181
13. Neubert, D., Chahoud, I., Platzek, T., Meister, R., 1987. Principles and problems in assessing prenatal toxicity. Arch. Toxicol. 60, 238-245.
14. Platzek T., and Schwabe R. Combined prenatal toxicity of 6-mercaptopurine riboside and hydroxyurea in mice. Teratog. Carcinog. Mutagen. 19 (1999) 223-232
15. Ritter E.J., Scott W.J., Wilson J.G., Mathinos P.R., and Randall J.L. Potentiative interactions between caffeine and various teratogenic agents. Teratology 25 (1982) 95-100
16. Salewski E. Färbemethoden zum makroskopischen Nachweis von Implantationsstellen am Uterus der Ratte. Naunyn Schmiedebergs Arch. Exp. Pathol. Pharmakol. 247 (1964) 367
17. Solecki R., Bürgin H., Buschmann J., Clark R., Duverger M., Fialkowski O., Guittin P., Hazelden K.P., Hellwig J., Hoffmann E., Hofmann T., Hübel U., Khalil S., Lingk W., Mantovani A., Moxon M., Müller S., Parkinson M., Paul M., Paumgartten F., Pfeil R., Platzek T., Rauch-Ernst M., Scheevelenbos A., Seed J., Talsness C.E., Yasuda M., Younes M., and Chahoud I. Harmonisation of rat fetal skeletal terminology and classification. Reprod. Toxicol. 15 (2001) 713-721
18. Thiel R., Dillmann I., Schimmel A., Bochert G., Chahoud I., and Neubert D. Aspects of designing postnatal studies. III. Persistence of skeletal anomalies induced prenatally. Teratology 40 (1989) 300
19. Tyl R.W., Chernoff N., and Rogers J.M. Altered axial skeleton development. Birth Defects Res. Part B 80 (2007) 451-472
20. Thiersch J.B. Effect of 6-mercaptopurine on the rat fetus and reproduction in the rat. Ann. N.Y. Acad. Sci. 60 (1954) 220-227
21. US Environmental Protection Agency. Guidelines for developmental toxicity risk assessment. Fed. Regist. 56 (1991) 63798-63826